Carnegie Mellon: A Key Ruling For Biotech Patents

Law360, New York (September 15, 2008, 12:00 AM EDT) -- On Sep. 8, 2008, the United States Court of Appeals for the Federal Circuit ruled that certain claims of a patent owned by Carnegie Mellon University were invalid as lacking adequate written description. Carnegie Mellon University v. Hoffmann-La Roche Inc., Nos. 2007-1266; 2007-1267 (Fed. Cir. Sep. 8, 2008).

Despite arguments that the claims were directed to a biotechnology tool combining well-known elements and that one of the claimed elements had been a subject of scientific study since at least the 1970s, the court affirmed a lower...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.